Deleting SUV39H1 in CAR-T cells epigenetically enhances the antitumor function

doi:10.1002/mco2.552

PDF

MedComm ›› 2024, Vol. 5 ›› Issue (5) : e552. DOI: 10.1002/mco2.552

HIGHLIGHT

Deleting SUV39H1 in CAR-T cells epigenetically enhances the antitumor function

Yuning Wang, Guo Zhao, Shuhang Wang(), Ning Li()

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Yuning Wang, Guo Zhao, Shuhang Wang, Ning Li. Deleting SUV39H1 in CAR-T cells epigenetically enhances the antitumor function. MedComm, 2024, 5(5): e552 https://doi.org/10.1002/mco2.552

References

1	N Jain, Z Zhao, RP Koche, et al. Disruption of SUV39H1-mediated H3K9 methylation sustains CAR T-cell function. Cancer Discov. 2024;14(1):142-157.
2	S Lopez-Cobo, JR Fuentealba, P Gueguen, et al. SUV39H1 ablation enhances long-term CAR T function in solid tumors. Cancer Discov. 2024;14(1):120-141.
3	OK Dagher. Forks in the road for CAR T and CAR NK cell cancer therapies. Nat Immunol. 2023;24(12):1994-2007.
4	L Fang, Y Hao, H Yu, et al. Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity. Cancer Cell. 2023;41(6):e12.
5	LL Niborski, P Gueguen, M Ye, et al. CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas. Nat Commun. 2022;13(1):3739.